Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
6.01
-0.32 (-5.06%)
At close: Apr 23, 2026, 4:00 PM EDT
6.09
+0.08 (1.33%)
Pre-market: Apr 24, 2026, 8:18 AM EDT
Lexeo Therapeutics Employees
Lexeo Therapeutics had 59 employees as of December 31, 2025. The number of employees decreased by 13 or -18.06% compared to the previous year.
Employees
59
Change
-13
Growth
-18.06%
Revenue / Employee
n/a
Profits / Employee
-$1,694,254
Market Cap
445.26M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 59 | -13 | -18.06% |
| Sep 30, 2025 | 61 | -11 | -15.28% |
| Jun 30, 2025 | 61 | -8 | -11.59% |
| Mar 31, 2025 | 75 | 17 | 29.31% |
| Dec 31, 2024 | 72 | 14 | 24.14% |
| Sep 30, 2024 | 72 | 14 | 24.14% |
| Jun 30, 2024 | 69 | - | - |
| Dec 31, 2023 | 58 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Ginkgo Bioworks Holdings | 485 |
| REGENXBIO | 371 |
| Entrada Therapeutics | 152 |
| Invivyd | 122 |
| Aura Biosciences | 113 |
| Larimar Therapeutics | 71 |
| vTv Therapeutics | 26 |
LXEO News
- 24 days ago - Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights - GlobeNewsWire
- 7 weeks ago - Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February - GlobeNewsWire
- 3 months ago - Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics - GlobeNewsWire
- 3 months ago - Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy - GlobeNewsWire
- 4 months ago - Lexeo Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - Lexeo Therapeutics to Host Virtual Key Opinion Leader Event at the 22nd Global Cardiovascular Clinical Trialists (CVCT) Forum - GlobeNewsWire
- 6 months ago - Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights - GlobeNewsWire